regulation of interleukin-25 production

description: Any process that modulates the frequency, rate, or extent of interleukin-25 production.


name: positive regulation of hydrogen peroxide metabolic process

category: biolink:BiologicalProcess biolink:Occurrent biolink:OntologyClass biolink:BiologicalProcessOrActivity biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing biolink:PhysicalEssenceOrOccurrent

description: Any process that increases the frequency, rate or extent of the chemical reactions and pathways involving hydrogen peroxide.


regulation of dCDP biosynthetic process

description: Any process that modulates the frequency, rate or extent of dCDP biosynthetic process.


name: negative regulation of phosphatidic acid biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidic acid biosynthetic process.


name: positive regulation of nuclear-transcribed mRNA catabolic process, meiosis-specific transcripts

description: Any process that activates or increases the frequency, rate or extent of degradation of meiosis-specific nuclear transcribed transcripts during vegetative growth, by a mechanism that requires determinant of selective removal (DSR) sequences in the targeted mRNAs and involves a YTH family protein.


regulation of IP-10 production

description: Any process that modulates the frequency, rate, or extent of production of IP-10.


name: positive regulation of interleukin-32 production

description: Any process that activates or increases the frequency, rate or extent of interleukin-32 production.


name: positive regulation of 18-methylnonadec-1-ene metabolic process

description: Any process that activates or increases the frequency, rate or extent of 18-methylnonadec-1-ene metabolic process.


name: regulation of chemokine (C-C motif) ligand 5 production

description: Any process that modulates the frequency, rate, or extent of production of chemokine (C-C motif) ligand 5.


name: negative regulation of toluene catabolic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of toluene catabolic process.


name: positive regulation of nucleotide catabolic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of nucleotides.


name: positive regulation of purine nucleotide metabolic process

description: Any process that activates or increases the frequency, rate or extent of purine nucleotide metabolic process.


name: regulation of snRNA transcription by RNA polymerase II

description: Any process that modulates the frequency, rate or extent of snRNA transcription mediated by RNA polymerase II.


name: positive regulation of nonadec-1-ene biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of nonadec-1-ene biosynthetic process.


name: positive regulation of D-erythro-sphingosine kinase activity

description: Any process that activates or increases the frequency, rate or extent of D-erythro-sphingosine kinase activity.


name: positive regulation of amphiregulin production

description: Any process that activates or increases the frequency, rate or extent of production of amphiregulin.


positive regulation of tRNA methylation

description: Any process that activates or increases the frequency, rate or extent of tRNA methylation.


name: positive regulation of snoRNA processing

description: Any process that activates or increases the frequency, rate or extent of snoRNA processing.


name: negative regulation of interleukin-35 production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-35 production.


name: siRNA-mediated pericentric heterochromatin formation

description: The formation of pericentric heterochromatin by a process mediated by a small interfering RNA (siRNA).


name: regulation of methane biosynthetic process from methanethiol

description: Any process that modulates the frequency, rate or extent of methane biosynthetic process from methanethiol.


name: negative regulation of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process.


name: negative regulation of juvenile hormone catabolic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of juvenile hormone.


name: positive regulation of brassinosteroid biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of brassinosteroid biosynthetic process.


name: positive regulation of diacylglycerol biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of diacylglycerol biosynthetic process.


name: positive regulation of interleukin-27 production

description: Any process that activates or increases the frequency, rate, or extent of interleukin-27 production.


5' transitive RNA interference

description: An RNA interference where the silencing signal spreads 5' along the target mRNA, outside of the initial target sequence. Typically involves the formation of secondary siRNAs formed when the initial mRNA target sequence functions as a template for 5' to 3' synthesis of new dsRNA.


regulation of NAD+ kinase activity

description: Any process that modulates the frequency, rate or extent of NAD kinase activity, the catalysis of the transfer of a phosphate group, usually from ATP, to an NAD molecule.


name: carbon catabolite activation of transcription

description: A transcription regulation process in which the presence of one carbon source leads to an increase in the frequency, rate, or extent of transcription of specific genes involved in the metabolism of other carbon sources.


name: regulation of thiamine diphosphate biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of thiamine diphosphate.


name: positive regulation of pentadecane biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of pentadecane biosynthetic process.


name: regulation of polynucleotide 3'-phosphatase activity

description: Any process that modulates the frequency, rate or extent of polynucleotide 3'-phosphatase activity.


name: regulation of sarcinapterin metabolic process

description: Any process that modulates the frequency, rate or extent of sarcinapterin metabolic process.


name: regulation of fungal-type cell wall (1->3)-alpha-glucan biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of (1->3)-alpha glucans, compounds composed of glucose residues linked by (1->3)-alpha-D-glucosidic bonds, found in fungal-type cell walls, including those of ascospores.


name: positive regulation of transcription by RNA polymerase V

description: Any process that activates or increases the frequency, rate or extent of transcription mediated by RNA polymerase V.


name: positive regulation of tumor necrosis factor superfamily cytokine production

description: Any process that activates or increases the frequency, rate or extent of tumor necrosis factor superfamily cytokine production.


name: regulation of plasmacytoid dendritic cell cytokine production

description: Any process that modulates the frequency, rate, or extent of plasmacytoid dendritic cell cytokine production.


name: positive regulation of replicative senescence

description: Any process that activates or increases the frequency, rate or extent of replicative senescence.


name: positive regulation of interleukin-26 production

description: Any process that activates or increases the frequency, rate, or extent of interleukin-26 production.


name: regulation of sulfur amino acid metabolic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving sulfur amino acids.


name: co-transcriptional gene silencing by RNA interference machinery

description: A process in which the RNAi machinery mediates the degradation of nascent transcripts in association with chromatin.


name: sRNA-mediated post-transcriptional gene silencing

description: A post-transcriptional gene silencing pathway mediated by the action of small regulatory non-coding RNAs (sRNAs). sRNAs are 20-500 nucleotides in length and found in bacteria.


name: negative regulation of gene silencing by regulatory ncRNA

description: Any process that decreases the rate, frequency, or extent of gene silencing by RNA. Gene silencing by RNA is the process in which RNA molecules inactivate expression of target genes.


name: positive regulation of methane biosynthetic process from methylamine

description: Any process that activates or increases the frequency, rate or extent of methane biosynthetic process from methylamine.


name: positive regulation of antifungal peptide biosynthetic process

description: Any process that activates or increases the frequency, rate, or extent of antifungal peptide biosynthesis.


name: negative regulation of hydrogen sulfide biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen sulfide biosynthetic process.


regulation of DNA amplification

description: Any process that modulates the frequency, rate or extent of DNA amplification.


regulation of granzyme B production

description: Any process that modulates the frequency, rate, or extent of production of granzyme B.


name: positive regulation of cellular catabolic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of substances, carried out by individual cells.


name: positive regulation of tridecane metabolic process

description: Any process that activates or increases the frequency, rate or extent of tridecane metabolic process.


name: regulation of inositol-polyphosphate 5-phosphatase activity

description: Any process that modulates the rate or frequency of inositol-polyphosphate 5-phosphatase activity, the catalysis of the reactions: D-myo-inositol 1,4,5-trisphosphate + H2O = myo-inositol 1,4-bisphosphate + phosphate, and 1D-myo-inositol 1,3,4,5-tetrakisphosphate + H2O = 1D-myo-inositol 1,3,4-trisphosphate + phosphate.


name: positive regulation of N-acetylmuramic acid catabolic process

description: Any process that activates or increases the frequency, rate or extent of N-acetylmuramic acid catabolic process.


name: piRNA-mediated gene silencing by mRNA destabilization

description: A cytoplasmic post-transcriptional gene silencing pathway in which piRNAs direct the cleavage of target mRNAs. The target mRNA, often transcribed from a transposable element, is destabilized by the activity of a PIWI class endonuclease within the piRNA-induced silencing complex. This may also be accompanied by mRNA deadenylation and decapping.


name: regulation of dolichol biosynthetic process

description: Any process that modulates the frequency, rate or extent of dolichol biosynthesis. Dolichol biosynthesis consists of the chemical reactions and pathways resulting in the formation of dolichols, any 2,3-dihydropolyprenol derived from four or more linked isoprene units.


name: induction by virus of host reticulophagy

description: Any process in which a virus activates or increases the frequency, rate or extent of reticulophagy in the host.


regulation of bioluminescence

description: Any process that modulates the frequency, rate or extent of bioluminescence.


name: positive regulation of antibacterial peptide secretion

description: Any process that activates or increases the frequency, rate, or extent of antibacterial peptide secretion.


name: negative regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of biosynthesis of antibacterial peptides active against Gram-negative bacteria.


regulation of photosynthesis

description: Any process that modulates the frequency, rate or extent of photosynthesis.


name: positive regulation of production of molecular mediator of immune response

description: Any process that activates or increases the frequency, rate, or extent of the production of molecular mediator of immune response.


name: positive regulation of antibacterial peptide biosynthetic process

description: Any process that activates or increases the frequency, rate, or extent of antibacterial peptide biosynthesis.


name: regulation of sphingolipid biosynthetic process

description: Any process that modulates the rate, frequency or extent of sphingolipid biosynthesis. Sphingolipid biosynthesis is the chemical reactions and pathways resulting in the formation of sphingolipids, any of a class of lipids containing the long-chain amine diol sphingosine or a closely related base (a sphingoid).


name: negative regulation of T-helper 1 cell cytokine production

description: Any process that stops, prevents or reduces the frequency, rate or extent of T-helper 1 cell cytokine production.


name: negative regulation of antifungal peptide production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of antifungal peptide production.


name: regulation of post-transcriptional gene silencing by regulatory ncRNA

description: Any process that modulates the frequency, rate or extent of post-transcriptional gene silencing by a non-coding RNA.


name: positive regulation of 18-methylnonadec-1-ene biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of 18-methylnonadec-1-ene biosynthetic process.


name: negative regulation of electron transfer activity

description: Any process that stops, prevents or reduces the frequency, rate or extent of electron transfer activity.


name: negative regulation of tridecane metabolic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of tridecane metabolic process.


name: negative regulation of phytoalexin biosynthetic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of phytoalexin biosynthesis, the chemical reactions and pathways resulting in the formation of phytoalexins.


name: negative regulation of alkane biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of alkane biosynthetic process.


name: regulation of glucose-6-phosphatase activity

description: Any process that modulates the frequency, rate or extent of glucose-6-phosphatase activity, the catalysis of the reaction: D-glucose 6-phosphate + H2O = D-glucose + phosphate.


name: regulation of alkane biosynthetic process

description: Any process that modulates the frequency, rate or extent of alkane biosynthetic process.


name: negative regulation of sulfur amino acid metabolic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving sulfur amino acids.


name: positive regulation of hexadecanal metabolic process

description: Any process that activates or increases the frequency, rate or extent of hexadecanal metabolic process.


name: regulation of transcription by RNA polymerase V

description: Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase V.


name: negative regulation of interleukin-11 production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-11 production.


name: regulation of mast cell cytokine production

description: Any process that modulates the frequency, rate, or extent of mast cell cytokine production.


name: regulation of thiamine biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of thiamine.


name: positive regulation of phosphatidate phosphatase activity

description: Any process that activates or increases the frequency, rate or extent of phosphatidate phosphatase activity.


name: negative regulation of estrogen biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of estrogen biosynthetic process.


name: negative regulation of interleukin-22 production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-22 production.


name: regulation of nucleotide catabolic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of nucleotides.


name: regulation of tatiopterin metabolic process

description: Any process that modulates the frequency, rate or extent of tatiopterin metabolic process.


name: negative regulation of chemokine (C-C motif) ligand 20 production

description: Any process that stops, prevents or reduces the frequency, rate or extent of chemokine (C-C motif) ligand 20 production.


name: negative regulation of autophagy of mitochondrion

description: Any process that stops, prevents or reduces the frequency, rate or extent of mitochondrion degradation by autophagy.


name: negative regulation of UDP-N-acetylglucosamine biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of the UDP-N-acetylglucosamine biosynthetic process.


name: regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria

description: Any process that modulates the frequency, rate, or extent of biosynthesis of antibacterial peptides active against Gram-negative bacteria.


name: positive regulation of sphingolipid biosynthetic process

description: Any process that increases the rate, frequency or extent of sphingolipid biosynthesis. Sphingolipid biosynthesis is the chemical reactions and pathways resulting in the formation of sphingolipids, any of a class of lipids containing the long-chain amine diol sphingosine or a closely related base (a sphingoid).


name: regulation of chitin biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of chitin.


regulation of interleukin-17 production

description: Any process that modulates the frequency, rate, or extent of production of any member of the interleukin-17 family of cytokines.


regulation of mRNA catabolic process

description: Any process that modulates the rate, frequency, or extent of a mRNA catabolic process, the chemical reactions and pathways resulting in the breakdown of RNA, ribonucleic acid, one of the two main type of nucleic acid, consisting of a long, unbranched macromolecule formed from ribonucleotides joined in 3',5'-phosphodiester linkage.


name: positive regulation of sulfate assimilation

description: Any process that activates or increases the frequency, rate or extent of sulfate assimilation.


name: positive regulation of (R)-mevalonic acid biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of (R)-mevalonic acid biosynthetic process.


name: negative regulation of antibacterial peptide biosynthetic process

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of antibacterial peptide biosynthesis.


regulation of interleukin-35 production

description: Any process that modulates the frequency, rate, or extent of interleukin-35 production.


name: regulation of UDP-glucose catabolic process

description: Any process that modulates the rate, frequency or extent of UDP-glucose catabolism. UDP-glucose catabolic processes are the chemical reactions and pathways resulting in the breakdown of UDP-glucose, uridinediphosphoglucose, a substance composed of glucose in glycosidic linkage with uridine diphosphate.


name: positive regulation of capsule polysaccharide biosynthetic process

description: Any process that activates, maintains or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of polysaccharides that make up the capsule, a protective structure surrounding some species of bacteria and fungi.


name: regulation of mitochondrial mRNA catabolic process

description: Any process that modulates the frequency, rate or extent of mitochondrial mRNA catabolic process.


regulation of pre-miRNA processing

description: Any process that modulates the frequency, rate or extent of pre-microRNA processing.


name: negative regulation of removal of superoxide radicals

description: Any process that stops, prevents or reduces the frequency, rate or extent of removal of superoxide radicals.


name: negative regulation of phosphatidylserine metabolic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidylserine metabolic process.


name: regulation of nitric-oxide synthase biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of a nitric-oxide synthase enzyme.


name: induction of phytoalexin biosynthetic process

description: The activation of the chemical reactions and pathways resulting in the formation of phytoalexins, low-molecular mass, lipophilic antimicrobial compounds that accumulate rapidly at sites of incompatible pathogen infection.


name: regulation of fumagillin biosynthetic process

description: Any process that modulates the frequency, rate or extent of fumagillin biosynthetic process.


name: positive regulation of sarcinapterin metabolic process

description: Any process that activates or increases the frequency, rate or extent of sarcinapterin metabolic process.


name: regulation of purine nucleotide biosynthetic process

description: Any process that modulates the frequency, rate or extent of purine nucleotide biosynthetic processes.


regulation of interleukin-27 production

description: Any process that modulates the frequency, rate, or extent of interleukin-27 production.


name: negative regulation of heptadecane biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of heptadecane biosynthetic process.


name: positive regulation of sulfur metabolic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving sulfur or compounds containing sulfur.


name: nuclear mRNA surveillance of mRNP export

description: The set of processes involved in identifying and degrading incorrectly formed or aberrant nuclear mRNPs docked at the nuclear pore complex prior to export to the cytoplasm.


name: positive regulation of ent-pimara-8(14),15-diene biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of ent-pimara-8(14),15-diene biosynthetic process.


name: negative regulation of post-transcriptional gene silencing

description: Any process that decreases the frequency, rate or extent of the inactivation of gene expression by a posttranscriptional mechanism.


name: positive regulation of camalexin biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of camalexin biosynthetic process.


name: negative regulation of ent-pimara-8(14),15-diene biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of ent-pimara-8(14),15-diene biosynthetic process.


name: negative regulation of sulfur metabolic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving sulfur or compounds containing sulfur.


name: negative regulation of B cell cytokine production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of B cell cytokine production.


name: positive regulation of polynucleotide 3'-phosphatase activity

description: Any process that activates or increases the frequency, rate or extent of polynucleotide 3'-phosphatase activity.


name: negative regulation of tridecane biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of tridecane biosynthetic process.


name: regulation of photosynthesis, light reaction

description: Any process that modulates the frequency, rate or extent of the light-dependent reaction of photosynthesis.


regulation of sulfate assimilation

description: Any process that modulates the frequency, rate or extent of sulfate assimilation.


name: negative regulation of phospholipid metabolic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of phospholipid metabolic process.


name: negative regulation of cellular biosynthetic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of substances, carried out by individual cells.


name: regulation of glycolytic fermentation to ethanol

description: Any process that modulates the frequency, rate or extent of glucose catabolic process to ethanol.


name: regulation of hydrogen peroxide biosynthetic process

description: Any process that modulates the rate, frequency or extent of hydrogen peroxide biosynthesis. The chemical reactions and pathways resulting in the formation of hydrogen peroxide (H2O2), a potentially harmful byproduct of aerobic cellular respiration which can cause damage to DNA.


name: regulation of nonadec-1-ene biosynthetic process

description: Any process that modulates the frequency, rate or extent of nonadec-1-ene biosynthetic process.


name: positive regulation of phosphate metabolic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving phosphates.


name: regulation of chemokine (C-C motif) ligand 6 production

description: Any process that modulates the frequency, rate, or extent of production of chemokine (C-C motif) ligand 6 (CCL6).


regulation of piRNA transcription

description: Any process that modulates the frequency, rate or extent of the synthesis of a piRNA.


name: negative regulation of antimicrobial peptide biosynthetic process

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of antimicrobial peptide biosynthesis.


name: negative regulation of sarcinapterin metabolic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of sarcinapterin metabolic process.


name: regulation of ascospore wall beta-glucan biosynthetic process

description: Any process that modulates the rate, frequency or extent of ascospore wall beta-glucan biosynthetic process, the chemical reactions and pathways resulting in the formation of beta-glucans, compounds composed of glucose residues linked by beta-D-glucosidic bonds, found in the walls of ascospores.


name: negative regulation of myeloid dendritic cell cytokine production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of myeloid dendritic cell cytokine production.


name: regulation of fructose 1,6-bisphosphate 1-phosphatase activity

description: Any process that modulates the rate, frequency or extent of fructose 1,6-bisphosphate 1-phosphatase activity. Fructose 1,6-bisphosphate 1-phosphatase activity is the catalysis of the reaction: D-fructose 1,6-bisphosphate + H2O = D-fructose 6-phosphate + phosphate.


name: negative regulation of photosynthesis, light reaction

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the light-dependent reaction of photosynthesis.


name: regulation of hydrogen peroxide catabolic process

description: Any process that modulates the frequency, rate or extent of hydrogen peroxide catabolic process.


name: regulation of cellular organohalogen metabolic process

description: Any process that modulates the rate, frequency or extent of the chemical reactions and pathways involving organohalogen compounds, as carried out by individual cells.


name: positive regulation of interleukin-20 production

description: Any process that activates or increases the frequency, rate, or extent of interleukin-20 production.


name: negative regulation of interleukin-17A production

description: Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-17A production.


photosystem II stabilization

description: The stabilization of the photosystem II protein complex, resulting from the phosphorylation of its structural protein subunits, in a cell actively involved in photosynthesis.


regulation of interleukin-22 production

description: Any process that modulates the frequency, rate, or extent of interleukin-22 production.


name: retrotransposon silencing by piRNA-directed DNA methylation

description: A retrotransposon silencing mechanism mediated by Piwi-associated RNA (piRNA)-directed DNA methylation. This results in a heterochromatin assembly, a chromatin conformation that is refractory to transcription.


regulation of lncRNA transcription

description: Any process that modulates the frequency, rate or extent of the synthesis of a lncRNA.


name: positive regulation of interleukin-11 production

description: Any process that activates or increases the frequency, rate, or extent of interleukin-11 production.


name: positive regulation of removal of superoxide radicals

description: Any process that activates or increases the frequency, rate or extent of removal of superoxide radicals.


negative regulation of xenophagy

description: Any process that stops, prevents or reduces the frequency, rate or extent of xenophagy.


name: regulation of diacylglycerol kinase activity

description: Any process that modulates the frequency, rate or extent of diacylglycerol kinase activity.


name: negative regulation of amylopectin catabolic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of amylopectin catabolic process.


name: negative regulation of interleukin-15 production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-15 production.


name: nuclear-transcribed mRNA catabolic process, meiosis-specific transcripts

description: The chemical reactions and pathways resulting in the selective degradation of meiosis-specific transcripts during vegetative growth, by a mechanism that requires determinant of selective removal (DSR) sequences in the targeted mRNAs and involves a YTH family protein.


name: RNAi-mediated antiviral immunity against DNA virus

description: An RNAi-mediated post-transcriptional gene silencing pathway induced by DNA viruses leading to a sequence-specific degradation of target mRNAs or inhibition of translation. In plants, DCL3 is the primary Dicer to detect DNA viruses.


name: negative regulation of (1->3)-beta-D-glucan biosynthetic process

description: Any process that decreases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of (1->3)-beta-D-glucans.


name: negative regulation of thyroid hormone generation

description: Any process that stops, prevents or reduces the frequency, rate or extent of thyroid hormone generation.


regulation of replicative senescence

description: Any process that modulates the frequency, rate or extent of replicative senescence.


name: negative regulation of chemokine (C-C motif) ligand 1 production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of production of chemokine (C-C motif) ligand 1.


name: negative regulation of phosphate metabolic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving phosphates.


name: negative regulation of interleukin-21 production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-21 production.


name: regulation of methane biosynthetic process from methylamine

description: Any process that modulates the frequency, rate or extent of methane biosynthetic process from methylamine.


name: regulation of interleukin-17A production

description: Any process that modulates the frequency, rate or extent of interleukin-17A production.


name: dosage compensation by hyperactivation of X chromosome

description: Compensating for the two-fold variation in X-chromosome:autosome ratios between sexes by a global hyperactivation of all, or most of, the genes on the X-chromosome in the heterogametic sex, leading to a two-fold increase in gene expression from this chromosome. An example of this is found in Drosophila melanogaster.


name: negative regulation of isoprenoid metabolic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving isoprenoid.


name: negative regulation of cellular organohalogen metabolic process

description: Any process that decreases the rate, frequency or extent of the chemical reactions and pathways involving organohalogen compounds, as carried out by individual cells.


name: positive regulation of purine nucleotide biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of purine nucleotide biosynthetic processes.


name: positive regulation of thiamine biosynthetic process

description: Any process that increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of thiamine.


description: The organization of chromatin into heterochromatin at the pericentric region of a chromosome.


regulation of glucokinase activity

description: Any process that modulates the frequency, rate or extent of glucokinase activity, the catalysis of the transfer of a phosphate group, usually from ATP, to a glucose molecule.


name: negative regulation of glial cell-derived neurotrophic factor production

description: Any process that stops, prevents or reduces the frequency, rate or extent of glial cell-derived neurotrophic factor production.


name: regulation of plant-type cell wall cellulose biosynthetic process

description: Any process that modulates the frequency, rate or extent of plant-type cell wall cellulose biosynthetic process.


name: negative regulation of phosphorus utilization

description: Any process that stops, prevents, or reduces the frequency, rate or extent of phosphorus utilization.


name: regulation of cellular biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of substances, carried out by individual cells.


photosynthetic state transition

description: A regulation of the phtosynthetic light reaction in which the light harvesting antenna complexes transition between photosystems.


name: negative regulation of alkaline phosphatase activity

description: Any process that decreases the frequency, rate or extent of alkaline phosphatase activity, the catalysis of the reaction: an orthophosphoric monoester + H2O = an alcohol + phosphate, with an alkaline pH optimum.


name: positive regulation of isoprenoid metabolic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving isoprenoid.


name: negative regulation of mitochondrial ATP synthesis coupled proton transport

description: Any process that stops, prevents or reduces the frequency, rate or extent of mitochondrial ATP synthesis coupled proton transport.


name: positive regulation of phosphorus metabolic process

description: Any process that increases the frequency, rate or extent of the chemical reactions and pathways involving phosphorus or compounds containing phosphorus.


name: regulation of inositol trisphosphate biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of inositol trisphosphate.


name: regulation of phosphatidate phosphatase activity

description: Any process that modulates the frequency, rate or extent of phosphatidate phosphatase activity.


name: nuclear-transcribed mRNA catabolic process, 5'-3' exonucleolytic nonsense-mediated decay

description: The chemical reactions and pathways resulting in the breakdown of the nuclear-transcribed mRNA transcript body of an mRNA in which an amino-acid codon has changed to a nonsense codon; occurs when the 5' end is not protected by a 5'-cap; degradation proceeds in the 5' to 3' direction.


name: positive regulation of estrogen biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of estrogen biosynthetic process.


name: regulation of promoter clearance from RNA polymerase II promoter

description: A process that modulates the frequency, rate or extent of the transition from the initiation to the elongation phases of transcription by RNA polymerase II.


name: negative regulation of methane biosynthetic process from methanethiol

description: Any process that stops, prevents or reduces the frequency, rate or extent of methane biosynthetic process from methanethiol.


name: positive regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay

description: Any process that activates or increases the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay.


name: regulation of gene silencing by regulatory ncRNA

description: Any process that regulates the rate, frequency, or extent of gene silencing by RNA. Gene silencing by RNA is the process in which RNA molecules inactivate expression of target genes.


name: positive regulation of interleukin-34 production

description: Any process that activates or increases the frequency, rate or extent of interleukin-34 production.


name: regulation of termination of RNA polymerase II transcription

description: Any process that modulates the frequency, rate or extent of termination of RNA polymerase II transcription.


name: positive regulation of pyrimidine-containing compound salvage

description: Any process that activates or increases the frequency, rate or extent of pyrimidine-containing compound salvage.


name: positive regulation of juvenile hormone metabolic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving juvenile hormone.


negative regulation of bioluminescence

description: Any process that stops, prevents or reduces the frequency, rate or extent of bioluminescence.


regulation of amphiregulin production

description: Any process that modulates the frequency, rate, or extent of production of amphiregulin.


name: positive regulation of interleukin-25 production

description: Any process that activates or increases the frequency, rate, or extent of interleukin-25 production.


name: regulation of brassinosteroid biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of brassinosteroids.


name: regulation of coenzyme A biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving coenzyme A.


name: regulation of heptadecane biosynthetic process

description: Any process that modulates the frequency, rate or extent of heptadecane biosynthetic process.


name: positive regulation of octadecene metabolic process

description: Any process that activates or increases the frequency, rate or extent of octadecene metabolic process.


name: negative regulation of methane biosynthetic process from dimethyl sulfide

description: Any process that stops, prevents or reduces the frequency, rate or extent of methane biosynthetic process from dimethyl sulfide.


name: positive regulation of interleukin-35 production

description: Any process that activates or increases the frequency, rate, or extent of interleukin-35 production.


name: regulation of vitamin D biosynthetic process

description: Any process that modulates the rate frequency or extent of a vitamin D biosynthetic process. Vitamin D biosynthesis is the chemical reactions and pathways resulting in the formation of vitamin D, any of a group of related, fat-soluble compounds that are derived from delta-5,7 steroids and play a central role in calcium metabolism. Specific forms of vitamin D include calciferol (ergocalciferol; vitamin D2) and cholecalciferol (calciol; vitamin D3).


name: retrotransposon silencing by siRNA-directed DNA methylation

description: A retrotransposon silencing mechanism mediated by RNA-directed DNA methylation. RNA-directed DNA methylation is a gene silencing process in which small interfering RNAs (siRNAs) guide DNA methylation to the siRNA-generating genomic loci and other loci that are homologous to the siRNAs for de novo DNA methylation. This results in a heterochromatin assembly, a chromatin conformation that is refractory to transcription.


name: regulation of antimicrobial peptide production

description: Any process that modulates the frequency, rate, or extent of antimicrobial peptide production.


name: regulation of alpha-glucan biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways relusting in the formation of alpha-glucans.


name: negative regulation of production of molecular mediator of immune response

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of the production of molecular mediator of immune response.


name: negative regulation of oxytocin production

description: Any process that stops, prevents, or reduces the rate of production of oxytocin.


name: positive regulation of interleukin-22 production

description: Any process that activates or increases the frequency, rate, or extent of interleukin-22 production.


name: positive regulation of glycolytic fermentation to ethanol

description: Any process that activates or increases the frequency, rate or extent of glucose catabolic process to ethanol.


name: positive regulation of pyrimidine nucleotide biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of pyrimidine nucleotide biosynthetic process.


name: regulation of 18-methylnonadec-1-ene biosynthetic process

description: Any process that modulates the frequency, rate or extent of 18-methylnonadec-1-ene biosynthetic process.


name: negative regulation of ergosterol biosynthetic process

description: Any process that decreases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of ergosterol.


name: regulation of cellulose biosynthetic process

description: Any process that modulates the frequency, rate or extent of cellulose biosynthetic process.


name: negative regulation of hexadecanal biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of hexadecanal biosynthetic process.


description: The formation of heterochromatin into a heterochromatin domain, enriched in histone H3 methylated on lysine 9 (H3K9me), by a process mediated by a Piwi-associated RNA (piRNA).


name: positive regulation of amylopectin catabolic process

description: Any process that activates or increases the frequency, rate or extent of amylopectin catabolic process.


regulation of snoRNA processing

description: Any process that modulates the frequency, rate or extent of snoRNA processing.


photosystem stoichiometry adjustment

description: Adjustment of Photosystem I/Photosystem II ratio in response to light conditions. The function of photosystem stoichiometry adjustment is to compensate for any deficiency in energy conversion at either photosystem I or photosystem II by increasing the quantity the photosystem that will otherwise become the rate-limiting to overall photosynthesis.


name: regulation of interferon-alpha production

description: Any process that modulates the frequency, rate, or extent of interferon-alpha production.


name: negative regulation of macrophage inflammatory protein-1 gamma production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of production of macrophage inflammatory protein-1 gamma.


name: regulation of pentadecane metabolic process

description: Any process that modulates the frequency, rate or extent of pentadecane metabolic process.


name: positive regulation of post-transcriptional gene silencing

description: Any process that increases the frequency, rate or extent of the inactivation of gene expression by a posttranscriptional mechanism.


name: positive regulation of phytol biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of phytol biosynthetic process.


name: negative regulation of interleukin-7 production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-7 production.


name: regulation of hydrogen sulfide biosynthetic process

description: Any process that modulates the frequency, rate or extent of hydrogen sulfide biosynthetic process.


name: regulation of mitochondrial electron transport, NADH to ubiquinone

description: Any process that modulates the frequency, rate or extent of mitochondrial electron transport, NADH to ubiquinone.


name: regulation of transforming growth factor beta1 production

description: Any process that modulates the frequency, rate, or extent of production of transforming growth factor-beta1.


name: regulation of mRNA cis splicing, via spliceosome

description: Any process that modulates the frequency, rate or extent of mRNA cis splicing, via spliceosome.


RNAi-mediated antiviral immune response

description: A post-transcriptional gene silencing pathway mediated by the action of regulatory RNAs that protects against foreign organism invasion by restricting viral replication and dissemination.


name: regulation of myeloid dendritic cell cytokine production

description: Any process that modulates the frequency, rate, or extent of myeloid dendritic cell cytokine production.


name: negative regulation of sphingolipid biosynthetic process

description: Any process that decreases the rate, frequency or extent of sphingolipid biosynthesis. Sphingolipid biosynthesis is the chemical reactions and pathways resulting in the formation of sphingolipids, any of a class of lipids containing the long-chain amine diol sphingosine or a closely related base (a sphingoid).


name: regulation of (1->3)-beta-D-glucan biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of (1->3)-beta-D-glucans.


name: positive regulation of DNA amplification

description: Any process that activates or increases the frequency, rate or extent of DNA amplification.


positive regulation of bioluminescence

description: Any process that activates or increases the frequency, rate or extent of bioluminescence.


name: regulation of hexadecanal biosynthetic process

description: Any process that modulates the frequency, rate or extent of hexadecanal biosynthetic process.


name: regulation of electron transfer activity

description: Any process that modulates the frequency, rate or extent of electron transfer activity.


name: negative regulation of cellulose biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of cellulose biosynthetic process.


name: positive regulation of auxin biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of auxins, plant hormones that regulate aspects of plant growth.


name: positive regulation of chemokine (C-C motif) ligand 6 production

description: Any process that activates or increases the frequency, rate, or extent of production of chemokine (C-C motif) ligand 6 (CCL6).


regulation of interleukin-9 production

description: Any process that modulates the frequency, rate, or extent of interleukin-9 production.


regulation of nitrate assimilation

description: Any process that modulates the rate, frequency, or extent of the uptake, from the environment, of nitrates, inorganic or organic salts and esters of nitric acid and the subsequent reduction of nitrate ion to other, less highly oxidized, inorganic nitrogenous substances.


name: positive regulation of reverse transcription

description: Any process that activates or increases the frequency, rate or extent of reverse transcription.


constitutive heterochromatin formation

description: The compaction of chromatin into a conformation that is refactory to transcription.


name: positive regulation of auxin metabolic process

description: Any process that increases the frequency, rate or extent of the chemical reactions and pathways involving auxins, plant hormones that regulate aspects of plant growth.


name: regulation of 3'-UTR-mediated mRNA stabilization

description: Any process that modulates the frequency, rate or extent of 3'-UTR-mediated mRNA stabilization.


name: regulation of estrogen biosynthetic process

description: Any process that modulates the frequency, rate or extent of estrogen biosynthetic process.


name: regulation of juvenile hormone biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of juvenile hormone.


name: negative regulation of brassinosteroid biosynthetic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of brassinosteroids.


name: regulation of chemokine (C-C motif) ligand 20 production

description: Any process that modulates the frequency, rate or extent of chemokine (C-C motif) ligand 20 production.


name: regulation of chemokine (C-C motif) ligand 1 production

description: Any process that modulates the frequency, rate, or extent of production of chemokine (C-C motif) ligand 1.


name: regulation of transcription from RNA polymerase II promoter by a nonfermentable carbon source

description: A transcription regulation process in which the presence of a nonfermentable carbon source leads to the modulation of the frequency, rate, or extent of transcription, from an RNA polymerase II promoter, of specific genes involved in the metabolism of other carbon sources.


name: regulation of capsule polysaccharide biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of polysaccharides that make up the capsule, a protective structure surrounding some species of bacteria and fungi.


name: negative regulation of tatiopterin biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of tatiopterin biosynthetic process.


name: negative regulation of (R)-mevalonic acid biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of (R)-mevalonic acid biosynthetic process.


name: regulation of quinolinate biosynthetic process

description: Any process that modulates the frequency, rate or extent of quinolinate biosynthetic process.


name: suppression by virus of host type I interferon production

description: Any viral process that results in the inhibition of host cell type I interferon production. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.


regulation of endothelin production

description: Any process that modulates the frequency, rate or extent of endothelin production.


name: positive regulation of transcription by galactose

description: Any process involving galactose that activates or increases the rate of transcription.


name: positive regulation of isopentenyl diphosphate biosynthetic process, mevalonate pathway

description: Any process that activates or increases the frequency, rate or extent of isopentenyl diphosphate biosynthetic process, mevalonate pathway.


name: membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 isoform h1 (human)

description: A membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q86UL8-1.


protein EOLA1 isoform h2 (human)

A protein EOLA1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8TE69-2.


protein EOLA1 isoform h1 (human)

A protein EOLA1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8TE69-1.


name: alpha-1-antitrypsin N-glycosylated 1 (human)

description: An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-107 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P01009-1, Asn-107, MOD:00160~GNO:G00912UN.


name: YTH domain-containing family protein 3 phosphorylated 1 (human)

description: A YTH domain-containing family protein 3 (human) that has been phosphorylated on the residue at the position equivalent to Thr-115 of the amino acid sequence represented by UniProtKB:Q7Z739. UniProtKB:Q7Z739, Thr-115, MOD:00047.


name: cytosolic carboxypeptidase 1 isoform h1 (human)

description: A cytosolic carboxypeptidase 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UPW5-1.


distal convoluted tubule development

description: The process whose specific outcome is the progression of the distal convoluted tubule over time, from its formation to the mature structure. The distal convoluted tubule is the first segment of the nephron lying just downstream from the loop of Henle, immediately after the macula densa. Among other functions, in humans it is responsible for the reabsorption of about 5% of filtered sodium via the thiazide-sensitive Na-Cl symporter.


name: histone H3.2, initiator methionine removed citrullinated 1 (human)

description: A histone H3.2 (human) that has had the initiator methionine removed and that has been citrullinated at the position equivalent to Arg-9 of the amino acid sequence represented by UniProtKB:Q71DI3. UniProtKB:Q71DI3, 2-136, Arg-9, MOD:00219.


name: glycerol-3-phosphate acyltransferase 4 isoform 1 (human)

description: A glycerol-3-phosphate acyltransferase 4 isoform 1 that is encoded in the genome of human.


4-ketotorulene 3-hydroxylase activity

category: biolink:MolecularActivity biolink:Occurrent biolink:OntologyClass biolink:BiologicalProcessOrActivity biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing biolink:PhysicalEssenceOrOccurrent

description: Catalysis of the reaction: 4-ketotorulene + a reduced electron acceptor + oxygen = 3-hydroxy-4-ketotorulene + an oxidized electron acceptor + H2O.


notum development

description: The process whose specific outcome is the progression of the dorsal part of the body over time, from its formation to the mature structure.


name: zinc finger protein AEBP2 isoform h1 (human)

description: A zinc finger protein AEBP2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6ZN18-1.


name: vasopressin-neurophysin 2-copeptin sequence variant Q23R (human)

description: A vasopressin-neurophysin 2-copeptin (human) that has an Arg residue at the position equivalent to Gln-23 of the amino acid sequence represented by UniProtKB:P01185. UniProtKB:P01185, Gln-23, CHEBI:29952.


name: amyloid beta A4 precursor protein-binding family B member 1-interacting protein methylated 1 (human)

description: An amyloid beta A4 precursor protein-binding family B member 1-interacting protein (human) that has been methylated on the residue at the position equivalent to Cys-381 of the amino acid sequence represented by UniProtKB:Q7Z5R6-1. Example: UniProtKB:Q7Z5R6-1, Cys-381, MOD:00660.


name: pleckstrin homology domain-containing family A member 3 deaminated 1 (human)

description: A pleckstrin homology domain-containing family A member 3 (human) that has been deaminated on the residue at the position equivalent to Gln-288 of the amino acid sequence represented by UniProtKB:Q9HB20. UniProtKB:Q9HB20, Gln-288, MOD:00685.


name: pleckstrin homology domain-containing family A member 3

description: A protein that is a translation product of the human PLEKHA3 gene or a 1:1 ortholog thereof.


name: pleckstrin homology domain-containing family A member 3 cysteinylated 1 (human)

description: A pleckstrin homology domain-containing family A member 3 (human) that has been cysteinylated on the residue at the position equivalent to Cys-163 of the amino acid sequence represented by UniProtKB:Q9HB20. UniProtKB:Q9HB20, Cys-163, MOD:00765.


name: calcium/calmodulin-dependent protein kinase type II subunit delta, initiator methionine removed form (human)

description: A calcium/calmodulin-dependent protein kinase type II subunit delta (human) that has had the initiator methionine removed. Example: UniProtKB:Q13557-1, 2-499.


name: diacetyl reductase ((S)-acetoin forming) activity

description: Catalysis of the reaction: (S)-acetoin + NAD+ = diacetyl + H+ + NADH.


name: spermatid perinuclear RNA-binding protein isoform 1 (human)

description: A spermatid perinuclear RNA-binding protein isoform 1 that is encoded in the genome of human.


name: spermatid perinuclear RNA-binding protein

description: A protein that is a translation product of the human STRBP gene or a 1:1 ortholog thereof.


name: spermatid perinuclear RNA-binding protein deaminated 1 (human)

description: A spermatid perinuclear RNA-binding protein (human) that has been deaminated on the residue at the position equivalent to Asn-396 of the amino acid sequence represented by UniProtKB:Q96SI9-1. Example: UniProtKB:Q96SI9-1, Asn-396, MOD:00684.


name: spermatid perinuclear RNA-binding protein methylated 1 (human)

description: A spermatid perinuclear RNA-binding protein (human) that has been methylated on the residue at the position equivalent to Cys-218 of the amino acid sequence represented by UniProtKB:Q96SI9-1. Example: UniProtKB:Q96SI9-1, Cys-218, MOD:00660.


name: spermatid perinuclear RNA-binding protein isoform h2 (human)

description: A spermatid perinuclear RNA-binding protein (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96SI9-2.


name: spermatid perinuclear RNA-binding protein deaminated 2 (human)

description: A spermatid perinuclear RNA-binding protein (human) that has been deaminated on the residue at the position equivalent to Gln-397 of the amino acid sequence represented by UniProtKB:Q96SI9-1. Example: UniProtKB:Q96SI9-1, Gln-397, MOD:00685.


name: inter-alpha-trypsin inhibitor heavy chain H2 O-glycosylated 23 (human)

description: An inter-alpha-trypsin inhibitor heavy chain H2 (human) that has been O-glycosylated at the residue equivalent to Thr-675 of the amino acid sequence represented by UniProtKB:P19823-1, in which the glycan composition is represented by GlyTouCan:G57317CE. Example: UniProtKB:P19823-1, Thr-675, MOD:00005~GNO:G57317CE.


name: (+)-abscisic acid 8'-hydroxylase activity

description: Catalysis of the reaction: (+)-abscisate + H+ + NADPH + O2 = (+)-8'-hydroxyabscisate + H2O + NADP+.


cysteine-type deNEDDylase activity

description: An thiol-dependent isopeptidase activity that cleaves NEDD8 from a target protein to which it is conjugated.


corolla development

description: The process whose specific outcome is the progression of the corolla over time, from its formation to the mature structure.


name: elongation factor 1-gamma, initiator methionine removed form (human)

description: An elongation factor 1-gamma (human) that has had the initiator methionine removed. UniProtKB:P26641, 2-437.


name: dolichol phosphate-mannose biosynthesis regulatory protein sequence variant Y23C, initiator methionine removed form (human)

description: A dolichol phosphate-mannose biosynthesis regulatory protein (human) that has a Cys residue at the position equivalent to Tyr-23 of the amino acid sequence represented by UniProtKB:O94777 and that has had the initiator methionine removed. UniProtKB:O94777, 2-84, Tyr-23, CHEBI:29950.


name: dolichol phosphate-mannose biosynthesis regulatory protein isoform 1 (human)

description: A dolichol phosphate-mannose biosynthesis regulatory protein isoform 1 that is encoded in the genome of human.


name: dolichol phosphate-mannose biosynthesis regulatory protein, initiator methionine removed form (human)

description: A dolichol phosphate-mannose biosynthesis regulatory protein, initiator methionine removed form in human. UniProtKB:O94777, 2-84.


CD40 ligand N-glycosylated 19 (human)

A CD40 ligand (human) that has been N-glycosylated at the residue equivalent to Asn-240 of the amino acid sequence represented by UniProtKB:P29965-1, in which the glycan structure is represented by GlyTouCan:G78059CC. Example: UniProtKB:P29965-1, Asn-240, MOD:00160~GNO:G78059CC.


name: putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13 cysteinylated 3 (human)

description: A putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13 (human) that has been cysteinylated on the residue at the position equivalent to Cys-265 of the amino acid sequence represented by UniProtKB:Q9NP73-1. Example: UniProtKB:Q9NP73-1, Cys-265, MOD:00765.


F-box/WD repeat-containing protein 4

A protein that is a translation product of the human FBXW4 gene or a 1:1 ortholog thereof.


interleukin-3 production

description: The appearance of interleukin-3 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.


micronucleus organization

description: A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the micronucleus.


protein EVI2A isoform h2 (human)

A protein EVI2A (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P22794-2.


name: symbiont-mediated perturbation of host B-cell mediated immune response

description: A process in which a symbiont alters or subverts the B-cell mediated immune response of the host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.


name: nuclear receptor ROR-gamma isoform 1 (human)

description: A nuclear receptor ROR-gamma (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P51449-1.


name: nuclear receptor ROR-gamma phosphorylated 1 (human)

description: A nuclear receptor ROR-gamma (human) that has been phosphorylated on the residue at the position equivalent to Ser-113 of the amino acid sequence represented by UniProtKB:P51449-1. Example: UniProtKB:P51449-1, Ser-113, MOD:00046.


name: nuclear receptor ROR-gamma isoform h2 (human)

description: A nuclear receptor ROR-gamma (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P51449-2.


kazrin isoform h2 (human)

A kazrin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q674X7-2.


name: immunoglobulin heavy constant mu N-glycosylated 16 (human)

description: An immunoglobulin heavy constant mu (human) that has been N-glycosylated at the residue equivalent to Asn-209 of the amino acid sequence represented by UniProtKB:P01871-2, in which the glycan structure is represented by GlyTouCan:G65219TP. Example: UniProtKB:P01871-2, Asn-209, MOD:00160~GNO:G65219TP.


T-cell antigen CD7 deaminated 1 (human)

A T-cell antigen CD7 (human) that has been deaminated on the residue at the position equivalent to Asn-121 of the amino acid sequence represented by UniProtKB:P09564. UniProtKB:P09564, Asn-121, MOD:00684.


name: amyloid-beta precursor protein O-glycosylated 6 (human)

description: An amyloid-beta precursor protein (human) that has been O-glycosylated at the residue equivalent to Thr-367 of the amino acid sequence represented by UniProtKB:P05067-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05067-1, Thr-367, MOD:00005~GNO:G43417UB.


name: apoptotic chromatin condensation inducer in the nucleus phosphorylated 1 (human)

description: An apoptotic chromatin condensation inducer in the nucleus (human) that has been phosphorylated on the residue at the position equivalent to Ser-605 of the amino acid sequence represented by UniProtKB:Q9UKV3-1. Example: UniProtKB:Q9UKV3-1, Ser-605, MOD:00046.


name: apoptotic chromatin condensation inducer in the nucleus methylated 1 (human)

description: An apoptotic chromatin condensation inducer in the nucleus (human) that has been methylated on the residue at the position equivalent to Cys-1223 of the amino acid sequence represented by UniProtKB:Q9UKV3-1. Example: UniProtKB:Q9UKV3-1, Cys-1223, MOD:00660.


name: apoptotic chromatin condensation inducer in the nucleus isoform h4 (human)

description: An apoptotic chromatin condensation inducer in the nucleus (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UKV3-5.


name: apoptotic chromatin condensation inducer in the nucleus isoform h1 (human)

description: An apoptotic chromatin condensation inducer in the nucleus (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UKV3-1.


name: apoptotic chromatin condensation inducer in the nucleus isoform h2 (human)

description: An apoptotic chromatin condensation inducer in the nucleus (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UKV3-2.


name: apoptotic chromatin condensation inducer in the nucleus isoform h3 (human)

description: An apoptotic chromatin condensation inducer in the nucleus (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UKV3-3.


name: PALM2-AKAP2 fusion protein isoform 5 (human)

description: A PALM2-AKAP2 fusion protein (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9Y2D5-7.


name: histone H2A type 1-C, initiator methionine removed biotinylated 4 (human)

description: A histone H2A type 1-C (human) that has had the initiator methionine removed and that has been biotinylated at the position equivalent to Lys-126 of the amino acid sequence represented by UniProtKB:Q93077. UniProtKB:Q93077, 2-130, Lys-126, MOD:00126.


first cell cycle pseudocleavage

description: A process that occurs during the first cell cycle in an embryo, in which anterior cortical contractions culminate in a single partial constriction of the embryo called the pseudocleavage furrow. An example of this process is found in nematode worms.


pseudocleavage

description: Partial constriction of the cytoplasm of a cell to form a furrow that resembles a cleavage furrow but does not complete cytokinesis.


name: pseudocleavage involved in syncytial blastoderm formation

description: Formation of furrows in the cytoplasm between nuclei during cell cycles in embryos that contribute to the formation of the syncytial blastoderm. An example of this process is found in Drosophila melanogaster.


name: collagen alpha-1(XV) chain O-glycosylated 16 (human)

description: A collagen alpha-1(XV) chain (human) that has been O-glycosylated at the residue equivalent to Thr-513 of the amino acid sequence represented by UniProtKB:P39059-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P39059-1, Thr-513, MOD:00005~GNO:G53434XO.


name: DNA-directed RNA polymerase II subunit RPB1 deaminated 5 (human)

description: A DNA-directed RNA polymerase II subunit RPB1 (human) that has been deaminated on the residue at the position equivalent to Gln-703 of the amino acid sequence represented by UniProtKB:P24928-1. Example: UniProtKB:P24928-1, Gln-703, MOD:00685.


name: 26S proteasome regulatory subunit 8 isoform h2 (human)

description: A 26S proteasome regulatory subunit 8 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P62195-2.


name: 26S proteasome regulatory subunit 8 methylated 3 (human)

description: A 26S proteasome regulatory subunit 8 (human) that has been methylated on the residue at the position equivalent to Cys-363 of the amino acid sequence represented by UniProtKB:P62195-1. Example: UniProtKB:P62195-1, Cys-363, MOD:00660.


name: 26S proteasome regulatory subunit 8 methylated 2 (human)

description: A 26S proteasome regulatory subunit 8 (human) that has been methylated on the residue at the position equivalent to Cys-112 of the amino acid sequence represented by UniProtKB:P62195-1. Example: UniProtKB:P62195-1, Cys-112, MOD:00660.


name: 26S proteasome regulatory subunit 8 methylated 1 (human)

description: A 26S proteasome regulatory subunit 8 (human) that has been methylated on the residue at the position equivalent to Cys-209 of the amino acid sequence represented by UniProtKB:P62195-1. Example: UniProtKB:P62195-1, Cys-209, MOD:00660.


name: 26S proteasome regulatory subunit 8 cysteinylated 1 (human)

description: A 26S proteasome regulatory subunit 8 (human) that has been cysteinylated on the residue at the position equivalent to Cys-209 of the amino acid sequence represented by UniProtKB:P62195-1. Example: UniProtKB:P62195-1, Cys-209, MOD:00765.


name: 26S proteasome regulatory subunit 8 isoform h1 (human)

description: A 26S proteasome regulatory subunit 8 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P62195-1.


name: disintegrin and metalloproteinase domain-containing protein 18 isoform h3 (human)

description: A disintegrin and metalloproteinase domain-containing protein 18 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9Y3Q7-3.


name: zinc finger protein 808 methylated 1 (human)

description: A zinc finger protein 808 (human) that has been methylated on the residue at the position equivalent to Cys-852 of the amino acid sequence represented by UniProtKB:Q8N4W9-1. Example: UniProtKB:Q8N4W9-1, Cys-852, MOD:00660.


name: retinoblastoma-associated protein sequence variant S443*, initiator methionine removed form (human)

description: A retinoblastoma-associated protein (human) that has has been truncated after the position equivalent to Gly-442 of the amino acid sequence represented by UniProtKB:P06400 and that has had the initiator methionine removed. UniProtKB:P06400, 2-442.


name: serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform isoform 1 (human)

description: A serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform isoform 1 that is encoded in the genome of human.


name: first spliceosomal transesterification activity

description: Catalysis of the first transesterification reaction of spliceosomal mRNA splicing. The intron branch site adenosine is the nucleophile attacking the 5' splice site, resulting in cleavage at this position. In cis splicing, this is the step that forms a lariat structure of the intron RNA, while it is still joined to the 3' exon.


L(+)-tartrate dehydratase activity

description: Catalysis of the reaction: L-tartrate = H2O + oxaloacetate.


name: EF-hand calcium-binding domain-containing protein 6 isoform h6 (human)

description: An EF-hand calcium-binding domain-containing protein 6 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5THR3-6.


name: positive regulation of protein localization to adherens junction

description: Any process that activates or increases the frequency, rate or extent of protein localization to adherens junction. An adherens junction is a cell-cell junction composed of the epithelial cadherin-catenin complex at which the cytoplasmic face of the plasma membrane is attached to actin filaments.


name: B-cell antigen receptor complex-associated protein beta chain, signal peptide removed form (human)

description: A B-cell antigen receptor complex-associated protein beta chain (human) that has had the signal peptide removed. UniProtKB:P40259, 29-229.


name: B-cell antigen receptor complex-associated protein beta chain, signal peptide removed phosphorylated 1 (human)

description: A B-cell antigen receptor complex-associated protein beta chain (human) that has had the signal peptide removed and has been post-translationally modified to include phosphotyrosine at positions 196 and 207 of the amino acid sequence represented by UniProtKB:P40259. UniProtKB:P40259, 29-229, Tyr-196/Tyr-207, MOD:00048.


name: C-19 gibberellin 2-beta-dioxygenase activity

description: Catalysis of the reaction: a C-19 gibberellin + 2-oxoglutarate + O2 = a C-19 2-beta-hydroxygibberellin + succinate + CO2. C-19 gibberellin refers to a gibberellin with nineteen carbons.


gibberellin 2-beta-dioxygenase activity

description: Catalysis of the reaction: a gibberellin + 2-oxoglutarate + O2 = a 2-beta-hydroxygibberellin + succinate + CO2.


name: C-20 gibberellin 2-beta-dioxygenase activity

description: Catalysis of the reaction: a C-20 gibberellin + 2-oxoglutarate + O2 = a C-20 2-beta-hydroxygibberellin + succinate + CO2. C-20 gibberellin refers to a gibberellin with twenty carbons.


name: glutamate catabolic process via L-citramalate

description: The chemical reactions and pathways resulting in the breakdown of glutamate, via the intermediate L-citramalate.


name: zinc finger protein 506 methylated 1 (human)

description: A zinc finger protein 506 (human) that has been methylated on the residue at the position equivalent to Cys-147 of the amino acid sequence represented by UniProtKB:Q5JVG8-1. Example: UniProtKB:Q5JVG8-1, Cys-147, MOD:00660.


name: potassium voltage-gated channel subfamily D member 3 isoform 2 (human)

description: A voltage-gated potassium channel KCND3 isoform 2 that is encoded in the genome of human.


name: CCR4-NOT transcription complex subunit 2 isoform h2 (human)

description: A CCR4-NOT transcription complex subunit 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9NZN8-2.


name: coatomer subunit epsilon methylated 1 (human)

description: A coatomer subunit epsilon (human) that has been methylated on the residue at the position equivalent to Cys-212 of the amino acid sequence represented by UniProtKB:O14579-1. Example: UniProtKB:O14579-1, Cys-212, MOD:00660.


name: alpha-N-acetylgalactosaminidase N-glycosylated 57 (human)

description: An alpha-N-acetylgalactosaminidase (human) that has been N-glycosylated at the residue equivalent to Asn-201 of the amino acid sequence represented by UniProtKB:P17050-1, in which the glycan structure is represented by GlyTouCan:G77252PU. Example: UniProtKB:P17050-1, Asn-201, MOD:00160~GNO:G77252PU.


name: p21-activated protein kinase-interacting protein 1 cysteinylated 1 (human)

description: A p21-activated protein kinase-interacting protein 1 (human) that has been cysteinylated on the residue at the position equivalent to Cys-87 of the amino acid sequence represented by UniProtKB:Q9NWT1. UniProtKB:Q9NWT1, Cys-87, MOD:00765.


name: carboxypeptidase D O-glycosylated 12 (human)

description: A carboxypeptidase D (human) that has been O-glycosylated at the residue equivalent to Thr-44 of the amino acid sequence represented by UniProtKB:O75976-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:O75976-1, Thr-44, MOD:00005~GNO:G53434XO.


name: disintegrin and metalloproteinase domain-containing protein 11 isoform Short (human)

description: A disintegrin and metalloproteinase domain-containing protein 11 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O75078-2.


name: zinc finger and BTB domain-containing protein 14 isoform 1 (human)

description: A zinc finger and BTB domain-containing protein 14 isoform 1 that is encoded in the genome of human.


kit ligand isoform h3 (human)

A kit ligand (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P21583-3.


name: kit ligand isoform 1, signal peptide removed form (human)

description: A kit ligand isoform 1 (human) that has had the signal peptide removed. UniProtKB:P21583-1, 26-273.


kit ligand isoform 2 (human)

A kit ligand isoform 2 that is encoded in the genome of human.


kit ligand isoform 1 (human)

A kit ligand isoform 1 that is encoded in the genome of human.


neurotensin/neuromedin N

A protein that is a translation product of the human NTS gene or a 1:1 ortholog thereof.


name: cytoplasmic dynein 2 intermediate chain 1 acetylated 1 (human)

description: A cytoplasmic dynein 2 intermediate chain 1 (human) that has been acetylated on the residue at the position equivalent to Lys-691 of the amino acid sequence represented by UniProtKB:Q8WVS4. UniProtKB:Q8WVS4, Lys-691, MOD:00723.


name: superoxide dismutase [Mn], mitochondrial, transit peptide removed form (human)

description: A superoxide dismutase [Mn], mitochondrial (human) that has had the transit peptide removed. UniProtKB:P04179, 25-222.


apolipoprotein L3 isoform h2 (human)

An apolipoprotein L3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O95236-2.


name: general transcription factor IIH subunit 1 isoform h1 (human)

description: A general transcription factor IIH subunit 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P32780-1.


name: general transcription factor IIH subunit 1 deaminated 1 (human)

description: A general transcription factor IIH subunit 1 (human) that has been deaminated on the residue at the position equivalent to Asn-182 of the amino acid sequence represented by UniProtKB:P32780-1. Example: UniProtKB:P32780-1, Asn-182, MOD:00684.


name: general transcription factor IIH subunit 1 deaminated 2 (human)

description: A general transcription factor IIH subunit 1 (human) that has been deaminated on the residue at the position equivalent to Asn-375 of the amino acid sequence represented by UniProtKB:P32780-1. Example: UniProtKB:P32780-1, Asn-375, MOD:00684.


name: general transcription factor IIH subunit 1 isoform h2 (human)

description: A general transcription factor IIH subunit 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P32780-2.


name: general transcription factor IIH subunit 1 methylated 1 (human)

description: A general transcription factor IIH subunit 1 (human) that has been methylated on the residue at the position equivalent to Cys-181 of the amino acid sequence represented by UniProtKB:P32780-1. Example: UniProtKB:P32780-1, Cys-181, MOD:00660.


name: general transcription factor IIH subunit 1 cysteinylated 1 (human)

description: A general transcription factor IIH subunit 1 (human) that has been cysteinylated on the residue at the position equivalent to Cys-181 of the amino acid sequence represented by UniProtKB:P32780-1. Example: UniProtKB:P32780-1, Cys-181, MOD:00765.


olfactomedin-like protein 3

A protein that is a translation product of the human OLFML3 gene or a 1:1 ortholog thereof.


name: olfactomedin-like protein 3 N-glycosylated 5 (human)

description: An olfactomedin-like protein 3 (human) that has been N-glycosylated at the residue equivalent to Asn-248 of the amino acid sequence represented by UniProtKB:Q9NRN5-1, in which the glycan composition is represented by GlyTouCan:G69364JQ. Example: UniProtKB:Q9NRN5-1, Asn-248, MOD:00160~GNO:G69364JQ.


name: olfactomedin-like protein 3 N-glycosylated 4 (human)

description: An olfactomedin-like protein 3 (human) that has been N-glycosylated at the residue equivalent to Asn-248 of the amino acid sequence represented by UniProtKB:Q9NRN5-1, in which the glycan composition is represented by GlyTouCan:G65807AE. Example: UniProtKB:Q9NRN5-1, Asn-248, MOD:00160~GNO:G65807AE.


name: olfactomedin-like protein 3 isoform h3 (human)

description: An olfactomedin-like protein 3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9NRN5-3.


name: olfactomedin-like protein 3 N-glycosylated 1 (human)

description: An olfactomedin-like protein 3 (human) that has been N-glycosylated at the residue equivalent to Asn-177 of the amino acid sequence represented by UniProtKB:Q9NRN5-1, in which the glycan composition is represented by GlyTouCan:G19379ID. Example: UniProtKB:Q9NRN5-1, Asn-177, MOD:00160~GNO:G19379ID.


name: olfactomedin-like protein 3 isoform 1 (human)

description: An olfactomedin-like protein 3 isoform 1 that is encoded in the genome of human.


name: olfactomedin-like protein 3 N-glycosylated 3 (human)

description: An olfactomedin-like protein 3 (human) that has been N-glycosylated at the residue equivalent to Asn-177 of the amino acid sequence represented by UniProtKB:Q9NRN5-1, in which the glycan composition is represented by GlyTouCan:G83633GK. Example: UniProtKB:Q9NRN5-1, Asn-177, MOD:00160~GNO:G83633GK.


name: olfactomedin-like protein 3 N-glycosylated 2 (human)

description: An olfactomedin-like protein 3 (human) that has been N-glycosylated at the residue equivalent to Asn-177 of the amino acid sequence represented by UniProtKB:Q9NRN5-1, in which the glycan composition is represented by GlyTouCan:G50073PQ. Example: UniProtKB:Q9NRN5-1, Asn-177, MOD:00160~GNO:G50073PQ.


name: olfactomedin-like protein 3 isoform h2 (human)

description: An olfactomedin-like protein 3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9NRN5-2.


name: centriole, cilia and spindle-associated protein isoform h2 (human)

description: A centriole, cilia and spindle-associated protein (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6IQ19-2.


detection of jasmonic acid stimulus

description: The series of events in which a jasmonic acid stimulus is received by a cell and converted into a molecular signal. Series of events required for a jasmonic acid stimulus to be detected and converted to a signal molecule.


leukosialin O-glycosylated 167 (human)

A leukosialin (human) that has been O-glycosylated at the residue equivalent to Thr-58 of the amino acid sequence represented by UniProtKB:P16150-1, in which the glycan structure is represented by GlyTouCan:G60890ZT. Example: UniProtKB:P16150-1, Thr-58, MOD:00005~GNO:G60890ZT.


name: negative regulation of RNA import into nucleus

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the movement of RNA from the cytoplasm into the nucleus.


name: small ribosomal subunit protein eS8 cysteinylated 1 (human)

description: A small ribosomal subunit protein eS8 (human) that has been cysteinylated on the residue at the position equivalent to Cys-174 of the amino acid sequence represented by UniProtKB:P62241. UniProtKB:P62241, Cys-174, MOD:00765.


name: small ribosomal subunit protein eS8 methylated 1 (human)

description: A small ribosomal subunit protein eS8 (human) that has been methylated on the residue at the position equivalent to Cys-100 of the amino acid sequence represented by UniProtKB:P62241. UniProtKB:P62241, Cys-100, MOD:00660.


name: small ribosomal subunit protein eS8 methylated 2 (human)

description: A small ribosomal subunit protein eS8 (human) that has been methylated on the residue at the position equivalent to Cys-174 of the amino acid sequence represented by UniProtKB:P62241. UniProtKB:P62241, Cys-174, MOD:00660.


name: 40S ribosomal protein S8, initiator methionine removed form (human)

description: A small ribosomal subunit protein eS8 (human) that has had the initiator methionine removed. UniProtKB:P62241, 2-208.


name: small ribosomal subunit protein eS8 isoform 1 (human)

description: A small ribosomal subunit protein eS8 isoform 1 that is encoded in the genome of human.


name: small ribosomal subunit protein eS8 deaminated 1 (human)

description: A small ribosomal subunit protein eS8 (human) that has been deaminated on the residue at the position equivalent to Asn-84 of the amino acid sequence represented by UniProtKB:P62241. UniProtKB:P62241, Asn-84, MOD:00684.


dystonin deaminated 5 (human)

A dystonin (human) that has been deaminated on the residue at the position equivalent to Asn-1210 of the amino acid sequence represented by UniProtKB:Q03001-7. Example: UniProtKB:Q03001-7, Asn-1210, MOD:00684.


name: versican core protein O-glycosylated 140 (human)

description: A versican core protein (human) that has been O-glycosylated at the residue equivalent to Thr-1996 of the amino acid sequence represented by UniProtKB:P13611-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P13611-1, Thr-1996, MOD:00005~GNO:G53434XO.


name: interleukin-1 alpha isoform 1 myristoylated 2 (human)

description: An interleukin-1 alpha isoform 1 myristoylated 2 in human. UniProtKB:P01583-1, Lys-82, MOD:00087.


name: interleukin-1 alpha isoform 1 myristoylated 1 (human)

description: An interleukin-1 alpha isoform 1 myristoylated 1 in human. UniProtKB:P01583-1, Lys-83, MOD:00087.


interleukin-1 alpha isoform 1 (human)

An interleukin-1 alpha isoform 1 that is encoded in the genome of human.


name: interleukin-1 alpha isoform 1 cleaved 1 (human)

description: An interleukin-1 alpha isoform 1 cleaved 1 in human. UniProtKB:P01583-1, 113-271.


name: C4b-binding protein alpha chain N-glycosylated 8 (human)

description: A C4b-binding protein alpha chain (human) that has been N-glycosylated at the residue equivalent to Asn-506 of the amino acid sequence represented by UniProtKB:P04003-1, in which the glycan composition is represented by GlyTouCan:G73686WG. Example: UniProtKB:P04003-1, Asn-506, MOD:00160~GNO:G73686WG.


sorting nexin-33 isoform 1 (human)

A sorting nexin-33 isoform 1 that is encoded in the genome of human.


sorting nexin-33 deaminated 1 (human)

A sorting nexin-33 (human) that has been deaminated on the residue at the position equivalent to Gln-563 of the amino acid sequence represented by UniProtKB:Q8WV41. UniProtKB:Q8WV41, Gln-563, MOD:00685.


sorting nexin-33 deaminated 2 (human)

A sorting nexin-33 (human) that has been deaminated on the residue at the position equivalent to Gln-489 of the amino acid sequence represented by UniProtKB:Q8WV41. UniProtKB:Q8WV41, Gln-489, MOD:00685.


name: cell division control protein 6 homolog phosphorylated form (human)

description: A cell division control protein 6 homolog (human) that includes at least one phosphorylated residue. UniProtKB:Q99741, MOD:00696.


name: cell division control protein 6 homolog methylated 1 (human)

description: A cell division control protein 6 homolog (human) that has been methylated on the residue at the position equivalent to Cys-376 of the amino acid sequence represented by UniProtKB:Q99741. UniProtKB:Q99741, Cys-376, MOD:00660.


name: cell division control protein 6 homolog phosphorylated 1 (human)

description: A cell division control protein 6 homolog (human) that has been phosphorylated at Thr-37. UniProtKB:Q99741, Thr-37, MOD:00047.


name: cell division control protein 6 homolog methylated 3 (human)

description: A cell division control protein 6 homolog (human) that has been methylated on the residue at the position equivalent to Cys-156 of the amino acid sequence represented by UniProtKB:Q99741. UniProtKB:Q99741, Cys-156, MOD:00660.


name: cell division control protein 6 homolog methylated 4 (human)

description: A cell division control protein 6 homolog (human) that has been methylated on the residue at the position equivalent to Cys-493 of the amino acid sequence represented by UniProtKB:Q99741. UniProtKB:Q99741, Cys-493, MOD:00660.


name: cell division control protein 6 homolog deaminated 2 (human)

description: A cell division control protein 6 homolog (human) that has been deaminated on the residue at the position equivalent to Asn-308 of the amino acid sequence represented by UniProtKB:Q99741. UniProtKB:Q99741, Asn-308, MOD:00684.


name: cell division control protein 6 homolog methylated 2 (human)

description: A cell division control protein 6 homolog (human) that has been methylated on the residue at the position equivalent to Cys-506 of the amino acid sequence represented by UniProtKB:Q99741. UniProtKB:Q99741, Cys-506, MOD:00660.


name: cell division control protein 6 homolog deaminated 3 (human)

description: A cell division control protein 6 homolog (human) that has been deaminated on the residue at the position equivalent to Gln-356 of the amino acid sequence represented by UniProtKB:Q99741. UniProtKB:Q99741, Gln-356, MOD:00685.


name: cell division control protein 6 homolog deaminated 1 (human)

description: A cell division control protein 6 homolog (human) that has been deaminated on the residue at the position equivalent to Asn-342 of the amino acid sequence represented by UniProtKB:Q99741. UniProtKB:Q99741, Asn-342, MOD:00684.


name: cell division control protein 6 homolog cysteinylated 1 (human)

description: A cell division control protein 6 homolog (human) that has been cysteinylated on the residue at the position equivalent to Cys-156 of the amino acid sequence represented by UniProtKB:Q99741. UniProtKB:Q99741, Cys-156, MOD:00765.


TOM1-like protein 2 isoform h5 (human)

A TOM1-like protein 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6ZVM7-5.


name: vitamin K-dependent gamma-carboxylase isoform 1 (human)

description: A vitamin K-dependent gamma-carboxylase isoform 1 that is encoded in the genome of human.


name: lysosome-associated membrane glycoprotein 1, signal peptide removed form (human)

description: A lysosome-associated membrane glycoprotein 1 (human) that has had the signal peptide removed. Example: UniProtKB:P11279-1, 29-417.


name: interferon regulatory factor 7 isoform C (human)

description: An interferon regulatory factor 7 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q92985-3.


name: interferon regulatory factor 7 phosphorylated 1 (human)

description: An interferon regulatory factor 7 (human) that has been post-translationally modified to include phosphoserine at positions 477 and 479 of the amino acid sequence represented by UniProtKB:Q92985. UniProtKB:Q92985, Ser-477/Ser-479, MOD:00046.


name: interferon regulatory factor 7 isoform D (human)

description: An interferon regulatory factor 7 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q92985-4.


name: interferon regulatory factor 7 cysteinylated 1 (human)

description: An interferon regulatory factor 7 (human) that has been cysteinylated on the residue at the position equivalent to Cys-191 of the amino acid sequence represented by UniProtKB:Q92985-1. Example: UniProtKB:Q92985-1, Cys-191, MOD:00765.


name: interferon regulatory factor 7 isoform A (human)

description: An interferon regulatory factor 7 isoform 1 that is encoded in the genome of human.


name: interferon regulatory factor 7 unmodified form (human)

description: An interferon regulatory factor 7 unmodified form in human.


name: interferon regulatory factor 7 ubiquitinated form (human)

description: An interferon regulatory factor 7 (human) that includes at least one ubiquitinated lysine. UniProtKB:Q92985, MOD:01148.


name: interferon regulatory factor 7 methylated 2 (human)

description: An interferon regulatory factor 7 (human) that has been methylated on the residue at the position equivalent to Cys-191 of the amino acid sequence represented by UniProtKB:Q92985-1. Example: UniProtKB:Q92985-1, Cys-191, MOD:00660.


name: interferon regulatory factor 7 cysteinylated 2 (human)

description: An interferon regulatory factor 7 (human) that has been cysteinylated on the residue at the position equivalent to Cys-39 of the amino acid sequence represented by UniProtKB:Q92985-1. Example: UniProtKB:Q92985-1, Cys-39, MOD:00765.


name: interferon regulatory factor 7 methylated 1 (human)

description: An interferon regulatory factor 7 (human) that has been methylated on the residue at the position equivalent to Cys-97 of the amino acid sequence represented by UniProtKB:Q92985-1. Example: UniProtKB:Q92985-1, Cys-97, MOD:00660.


name: interferon regulatory factor 7 isoform B (human)

description: An interferon regulatory factor 7 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q92985-2.


name: interferon regulatory factor 7 isoform 1 unphosphorylated 1 (human)

description: An interferon regulatory factor 7 isoform 1 unphosphorylated 1 in human. UniProtKB:Q92985-1, Ser-477/Ser-479, PR:000026291.


name: regulation of store-operated calcium channel activity

description: Any process that modulates the frequency, rate or extent of store-operated calcium channel activity.


name: negative regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of the inositol 1,4,5-trisphosphate-sensitive calcium-release channel.


name: regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity

description: Any process that modulates the frequency, rate or extent of the activity of the inositol 1,4,5-trisphosphate-sensitive calcium-release channel.


name: regulation of light-activated voltage-gated calcium channel activity

description: Any process that modulates the frequency, rate or extent of light-activated voltage-gated calcium channel activity.


name: Cdc42-interacting protein 4 isoform h4 (human)

description: A Cdc42-interacting protein 4 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q15642-4.


description: The chemical reactions and pathways resulting in the breakdown of 3-methylbut-2-enoyl-CoA(4-).


name: phosphatase and actin regulator 1 isoform 1 (human)

description: A phosphatase and actin regulator 1 isoform 1 that is encoded in the genome of human.


name: atypical chemokine receptor 4 isoform 1 (human)

description: An atypical chemokine receptor 4 isoform 1 that is encoded in the genome of human.


name: transmembrane protein 138 isoform 1 (human)

description: A transmembrane protein 138 isoform 1 that is encoded in the genome of human.


name: peptidyl-arginine dihydroxylation to peptidyl-3,4-dihydroxy-L-arginine

description: The dihydroxylation of peptidyl-arginine to form peptidyl-3,4-dihydroxy-L-arginine.